Pharmaceuticals Inc
Last updated on 2013-11-20T06:45+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| Pharmaceuticals Inc | EN | 37.97% |
| Pharmaceuticals Inc | FR | 14.56% |
| Pharmaceuticals Inc | DE | 14.49% |
| Pharmaceuticals Inc | HR | 14.43% |
| Pharmaceuticals Inc | PT | 14.43% |
| Pharmaceutical Inc | EN | 3.26% |
| Pharmaceuticals Inc | SA | 0.40% |
| Pharmaceuticals. Inc | EN | 0.33% |
| Pharmaceutical Inc | FR | 0.07% |
| PHARMACEUTICALS INC | EN | 0.07% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 16.72% |
 | Commission | 3.70% |
| Drug Administration | 3.28% |
| British | 1.59% |
| GlaxoSmithKline | 1.59% |
| Pfizer Inc | 1.59% |
| Eli Lilly | 1.48% |
| Reuters Group | 1.38% |
| Acadia Pharmaceuticals | 1.16% |
| Renaissance | 1.06% |
| Law firm | 1.06% |
| Annual Meeting | 1.06% |
| Novartis | 1.06% |
| S government | 0.85% |
| GlaxoSmithKline Plc | 0.85% |
| Federal Reserve | 0.85% |
| SA | 0.85% |
| 0.85% | |
| Of The | 0.74% |
| Federal Reserve System | 0.74% |
| European Union | 0.74% |
| Laura Wood | 0.74% |
| CPI | 0.63% |
| Teva Pharmaceuticals | 0.63% |
| European Medicines Agency | 0.53% |
| Medicines Agency | 0.53% |
| Dow Jones | 0.53% |
| Goldman Sachs | 0.53% |
| Research Development | 0.53% |
| European Commission | 0.53% |
| Type | Entity Name | Score |
|---|---|---|
| Julio Aguirre Ghiso | 0.0238 |
| Inc | 0.0223 |
| Drug Administration | 0.0214 |
| Tachi Yamada | 0.0168 |
| Myles Clouston | 0.0156 |
| Mark Gillman | 0.0154 |
| GlaxoSmithKline | 0.0142 |
| Eli Lilly | 0.0131 |
| Acadia Pharmaceuticals | 0.0107 |
| Pharmaceutical Product Development Inc | 0.0103 |
| Annual Meeting | 0.0097 |
| Renaissance | 0.0095 |
| Novartis | 0.0093 |
| Law firm | 0.009 |
| Michael Macaluso | 0.0085 |
| GlaxoSmithKline Plc | 0.0078 |
| 0.0072 | |
| Teva Pharmaceuticals | 0.0059 |
| Tim Dyer | 0.0059 |
| Laura Wood | 0.0056 |
| Patrick Alexandre | 0.0054 |
| Research Development | 0.0052 |
| SA | 0.005 |
| Commission | 0.0041 |
| Ken Griffin | 0.0041 |
| Of The | 0.004 |
| Hart-Scott-Rodino | 0.004 |
| Hart-Scott-Rodino Antitrust Improvements | 0.004 |
| Boehringer Ingelheim | 0.004 |
| Product Development | 0.0039 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Friday, June 18, 2021
2:17:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 